ArticleRheumatology and therapy2022

Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab.

Uta Kiltz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.